Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $26.5900 (2.27%) ($26.5900 - $26.5900) on Thu. Jul. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.4% (three month average) | RSI | 73 | Latest Price | $26.5900(2.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.5% a day on average for past five trading days. | Weekly Trend | IOVA advances 5.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(45%) XBI(42%) IWO(41%) ARKG(40%) IWC(40%) | Factors Impacting IOVA price | IOVA will decline at least -3.2% in a week (0% probabilities). VIXM(-24%) UUP(-15%) VXX(-11%) TBT(-5%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.2% (StdDev 6.4%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $26.57(0.08%) | 10 Day Moving Average | $25.74(3.3%) | 20 Day Moving Average | $24.1(10.33%) | To recent high | -19.5% | To recent low | 64.5% | Market Cap | $3.894b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |